Human papillomavirus (HPV) vaccination is recommended in early adolescence, at an age
when other vaccines are also recommended. Administration of multiple vaccines during one …

ABSTRACT The Advisory Committee on Immunization Practices (ACIP) has recommended
human papillomavirus (HPV) vaccination for adolescents in the United States since 2006 …

The casual relationship concerning Human papillomaviruses (HPV) and cervical cancer is
already established. Therefore, such HPV-associated malignancies might be prevented by …

In 2006, the US Food and Drug Administration licensed the first vaccine against human
papillomavirus (HPV), Gardasil (Merck & Co). A second HPV vaccine, Cervarix …

Human papillomavirus (HPV), the most common sexually transmitted viral infection
worldwide, is the causative agent for cervical cancer and attributed to anogenital cancers as …

Recent publications reveal new information about the implementation of HPV vaccines.
Provider recommendation is a key approach, as is offering it routinely at the same time as …

Since human papillomavirus (HPV) vaccine was first introduced for females in the United
States in 2006, vaccination policy has evolved as additional HPV vaccines were licensed …

Human papillomavirus (HPV) vaccine uptake consistently lags behind that of other
adolescent vaccines. In 2017, uptake of a single HPV vaccine dose and HPV vaccine series …

Human papillomavirus (HPV) vaccines are available in the United States and around the
world to prevent HPV-associated diseases including cervical cancer and genital warts. HPV …

For middle and low-income countries, the cost of HPV vaccines remains challenging. We
conducted an open-label nonrandomized clinical trial evaluating immune response to the …